Skip to playerSkip to main contentSkip to footer
  • 1/27/2012
Last month the famous Israeli pharmaceutical company TEVA announced the resignation of its CEO. This month the foreign investors were surprised to find that TEVA's last quarter's profit rose to $2.280 billion. 

Category

🗞
News

Recommended